NEWARK Calif. May 30 2017 PRNewswire Protagonist Therapeutics Inc. Nasdaq PTGX today announced that the company has entered into a worldwide license and collaboration agreement with Janssen Biotech Inc. one of the Janssen Pharmaceutical Companies of Johns...
↧